4th Quarter - Termination
LUNGREN LOPINA LLC for AMPAC FINE CHEMICALS
Firm
Client
Income
$40,000
Expenses
—
Terminated
Dec 31, 2023
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Fair treatment for US based pharmaceutical ingredients
Foreign entity interest: A general interest in the success of AMPAC Fine Chemicals
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN LOPINA | — |
| DANIEL LUNGREN | Member of Congress |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| SK HOLDINGS | South Korea | South Korea | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.